Despite being the hallmark of cancer that is responsible for the highest number of deaths,
very little is known about the biology of metastasis. Metastatic disease typically manifests …

One of the most common cancers that occur in females is breast cancer. Despite the
significant leaps and bounds that have been made in treatment of breast cancer, the disease …

Breast cancer is a leading death cause in women globally. Since therapeutic products do
not yet approach the tumor tissue at adequate levels; therefore, nanoparticle-based …

The management of breast cancer during pregnancy (PrBC) is a relatively rare indication
and an area where no or little evidence is available since randomized controlled trials …

Background Breast cancer is the most frequent cancer in women and remains the second
leading cause of death in Western countries. It represents a heterogeneous group of …

Metastatic breast cancer is responsible for 90% of mortalities among women suffering from
various types of breast cancers. Traditional cancer treatments such as chemotherapy and …

Purpose To provide an organized, international, state-of-the-art, and multidisciplinary
guideline, led by experts of two nuclear medicine societies (EANM and SNMMI) and …

Objectives To calculate the pooled diagnostic performances of whole-body [18F] FDG
PET/MR in M staging of [18F] FDG-avid cancer entities. Methods A diagnostic meta-analysis …

Background and objectives Correct identification of estrogen receptor (ER) status in breast
cancer (BC) is crucial to optimize treatment; however, standard of care, involving biopsy and …

Simple Summary Breast cancer represents one of the most common cancers diagnosed in
female patients, with up to 75% of the patients with stage IV breast cancer developing …